Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome.
about
Cryptococcal meningitis: epidemiology and therapeutic options.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerClinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Development of fatal acute liver failure in HIV-HBV coinfected patients.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theVS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.Immune reconstitution inflammatory syndrome in HIV-infected patientsNovel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistanceImmune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient.The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome.Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab.Hepatitis B immune reconstitution syndrome in a patient with HIV infection.Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.
P2860
Q33633343-DDDB3FA2-9F75-4982-AE7E-53A8F2DD3CD9Q33650105-CEEAEB61-69F2-40DC-840A-825F1EB5A4ABQ34020746-FE645E1D-89E7-41AF-91B9-7AA58FF9DD1AQ34084999-36C976A8-8802-486D-9370-46BA79CD4285Q34212799-A5551523-D08D-46A6-AC5E-6AF5CC75726AQ34456352-D1D74561-90A3-4C9D-8F9B-7B7F232CCDCDQ35100818-FD9DC69D-D99B-48E5-A78D-A4D527A9B827Q37331456-BEF7698F-482D-4293-904F-D2A42B9CF968Q37821090-4E66F617-093C-42E3-8838-409DD8E2AB65Q38127598-A4AC33C8-07F0-4AD5-ADF3-932BCBD6E6A0Q40772316-ABC36231-922C-420F-A0F0-D67FB2D32D93Q40832429-F53E2AEB-02C6-4AFF-86C6-518FBCEADF11Q43087335-65E28893-36E8-488A-99EA-AE2408A98DDA
P2860
Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evidence base for using cortic ...... mmune reconstitution syndrome.
@ast
Evidence base for using cortic ...... mmune reconstitution syndrome.
@en
type
label
Evidence base for using cortic ...... mmune reconstitution syndrome.
@ast
Evidence base for using cortic ...... mmune reconstitution syndrome.
@en
prefLabel
Evidence base for using cortic ...... mmune reconstitution syndrome.
@ast
Evidence base for using cortic ...... mmune reconstitution syndrome.
@en
P2860
P356
P1476
Evidence base for using cortic ...... mmune reconstitution syndrome.
@en
P2093
Emil Lesho
P2860
P304
P356
10.1586/14787210.4.3.469
P577
2006-06-01T00:00:00Z